Highlights from the Quarter (Q1FY27):
Elecon Engineering Ltd. consolidated revenue reached Rs. 521 cr, a healthy 11.9% YoY growth over adjusted Q1 FY26 numbers. Despite a spike in input costs due to geopolitical tensions, EBITDA remained resilient at Rs.109 cr with a sustainable 21% margin on qoq basis. The consolidated open order book strengthened significantly, rising 36.8% YoY to Rs. 1,518 cr.
Gear Division (80% of Q1 Revenue)
Performance:: Revenue Rs.416 cr, +16.3% YoY; EBIT Rs.75 Cr (+14.7%), margin 17.9% vs 18.8% FY26 full-year. International = 36% of gear revenue, +37.6% YoY. Catalogue Product:Engineered Product revenue mix 54:46. Clients are sitting on low-cost inventory squeezed pricing. Mgmt frames Q1 as the “correction” phase, Q2 as “acceptance”, with Q3/Q4 the real pickup.
Material Handling Equipment (MHE) Division (20% of Q1 Revenue)
Performance: Revenue Rs.105 cr, -2.9% YoY (adj.); EBIT Rs.27 cr, -25.3% YoY, margin ~25.7% - still above FY26 full-year 24.7%. Two large power-sector orders were stuck at design-engineering clearance (EPC-contractor hierarchy); clearance expected in Q2 with revenue catch-up. Order Intake was +38.1% to Rs.185 cr; book Rs.475 cr, +18.8%.
Management Outlook & Forward Statements
Management remains optimistic about long-term growth despite near-term volatility:
• FY27: low double-digit consol. revenue growth, EBITDA margin held ~FY26 level (~21%) - explicitly conservative (US-Iran flare-up cited); may be revised up next quarter. Segment margins: Gear EBITDA ~24% (EBIT 19-20%); MHE EBITDA 22-24% sustainable. Exports guided to double-digit-plus growth. Capex Rs.400 cr over FY26-28 on track; further capex proposals heading to board.
• Medium term: FY30 topline target Rs.5,000 cr retained - “challenging but achievable” - Gear (incl. marine) ~70-75% of mix.
OUTLOOK AND VALUATION
We expect the company’s bottomline to grow at a CAGR of ~16% to Rs. 461 cr in FY26-28E. We view Elecon as a structurally strong play on India’s industrial capex and exports theme, with excellent financial health and execution capabilities. The investment thesis rests on: (1) sustained growth driven by infrastructure-led demand, (2) margin stability due to operational excellence, (3) potential upside from export penetration by tie up with OEMs. We expect the PAT and EPS to be at Rs. 461 Cr and Rs. 20.5 respectively. We have assigned a P/E multiple of 33X to arrive at a price target of Rs. 679 which provides an upside of ~42% within 18 to 24 months from the current market price.